Jpmorgan Chase & CO Astrazeneca PLC Transaction History

Jpmorgan Chase & CO

$1.51 Trillion
Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Astrazeneca PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 4,824,072 shares of AZN stock, worth $431 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,824,072

Previous 4,824,072 -0.0%

Holding current value

$431 Million

Previous $370 Million -0.0%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 07, 2025	BUY	$68.72 - $82.11 $15.8 Million - $18.8 Million	229,244 Added 4.99%	4,824,072 $370 Million
Q1 2025 May 12, 2025	SELL	$65.37 - $77.96 $42.7 Million - $50.9 Million	-652,805 Reduced 12.44%	4,594,828 $338 Million
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $4.74 Million - $5.97 Million	-75,054 Reduced 1.41%	5,247,633 $344 Million
Q3 2024 Dec 26, 2024	BUY	$76.67 - $87.62 $80.4 Million - $91.9 Million	1,048,290 Added 24.52%	5,322,687 $415 Million
Q3 2024 Nov 08, 2024	BUY	$76.67 - $87.62 $80.4 Million - $91.9 Million	1,048,290 Added 24.52%	5,322,687 $415 Million

Q2 2024 Dec 26, 2024	SELL	$66.81 - $80.83 $70 Million - $84.7 Million	-1,048,290 Reduced 19.69%	4,274,397 $333 Million
Q2 2024 Aug 12, 2024	BUY	$66.81 - $80.83 $19.4 Million - $23.5 Million	290,546 Added 7.29%	4,274,397 $333 Million
Q1 2024 Dec 26, 2024	SELL	$61.03 - $69.57 $81.7 Million - $93.1 Million	-1,338,836 Reduced 25.15%	3,983,851 $270 Million
Q1 2024 May 10, 2024	BUY	$61.03 - $69.57 $26.9 Million - $30.7 Million	441,441 Added 12.46%	3,983,851 $270 Million
Q4 2023 Dec 26, 2024	SELL	$61.89 - $69.28 $110 Million - $123 Million	-1,780,277 Reduced 33.45%	3,542,410 $239 Million
Q4 2023 Feb 12, 2024	BUY	$61.89 - $69.28 $92.5 Million - $104 Million	1,494,899 Added 73.01%	3,542,410 $239 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $1.89 Million - $2.09 Million	-29,081 Reduced 1.4%	2,047,511 $139 Million
Q2 2023 Aug 11, 2023	SELL	$69.91 - $75.81 $41 Million - $44.4 Million	-586,256 Reduced 22.02%	2,076,592 $149 Million
Q1 2023 May 11, 2023	SELL	$63.15 - $71.6 $42.6 Million - $48.3 Million	-674,329 Reduced 20.21%	2,662,848 $185 Million
Q4 2022 Feb 13, 2023	BUY	$54.21 - $70.44 $83.8 Million - $109 Million	1,545,443 Added 86.25%	3,337,177 $226 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $50.8 Million - $130 Million	958,359 Added 115.0%	1,791,734 $98.3 Million
Q2 2022 Aug 11, 2022	BUY	$59.26 - $71.14 $10 Million - $12 Million	169,380 Added 25.51%	833,375 $55.1 Million
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $14.7 Million - $17.7 Million	263,929 Added 65.97%	663,995 $44 Million
Q4 2021 Feb 10, 2022	SELL	$54.02 - $63.83 $60.2 Million - $71.2 Million	-1,115,017 Reduced 73.59%	400,066 $23.3 Million
Q3 2021 Nov 12, 2021	BUY	$55.56 - $60.79 $84.2 Million - $92.1 Million	1,515,083 New	1,515,083 $91 Million

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Astrazeneca PLC Transaction History